ORDER OF THE PRESIDENT OF THE PRESIDENT OF THE GENERAL COURT
8 April 2014 (1)
(Removal from the register)
In Case T-44/13 R-RENV,
AbbVie, Inc., established in Wilmington (United States)
AbbVie Ltd, established in Maidenhead (United Kingdom),
represented by P. Bogaert, lawyer, B. Kelly, G. Castle, Solicitors, D. Anderson, QC, and D. Scannell, Barrister,
applicants,
supported by,
European Federation of Pharmaceutical Industries and Associations (Efpia), established in Geneva (Switzerland),
and
Pharmaceutical Research and Manufacturers of America, established in Washington (United States),
represented by K. Bacon, Barrister, M. I. Utges Manley and M. A. Vickers, Solicitors,
interveners,
v
European Medicine Agency (EMA), represented by T. Jabłoński, N. Rampal Olmedo and A. Spina, acting as Agents,
defendant,
APPLICATION seeking, essentially, suspension of the operation of EMA decision EMA/748792/2012 of 14 January 2013 granting a third party access, pursuant to Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), to certain documents containing information submitted as part of an application for authorisation to place the medicinal product Humira, used to treat Crohn’s Disease, on the market.
1 By letter lodged at the Registry of the General Court on 31 March 2014, the applicants informed the Court, in accordance with Article 99 of the Rules of Procedure, that they wished to discontinue proceedings and that the question of costs had been the subject of an agreement between the parties, according to which the applicants and the defendant will bear their own costs.
2 By letter lodged at the Registry of the Court on 4 April 2014, the defendant informed the Court that it had no observations on the application for discontinuance and confirmed that the question of costs had been the subject of an agreement between the parties, according to which the applicants and the defendant will bear their own costs.
3 By letter lodged at the Registry of the Court on 4 April 2014, the intervener informed the Court that it had no observations on the application for discontinuance. It had no observations on the costs.
4 The case will therefore be removed from the register.
On those grounds,
THE PRESIDENT OF THE PRESIDENT OF THE GENERAL COURT
hereby orders:
1. Case T-44/13 R-RENV is removed from the register of the General Court.
2. The costs are reserved.
Luxembourg, 8 April 2014.